19 Jul Sex-dependent attentional impairments in a subchronic ketamine mouse model for schizophrenia
Abstract Development of more effective treatments for schizophrenia targeting cognitive and negative symptoms has been limited due partly to a disconnect between rodent models and human illness. Ketamine administration is widely used to model symptoms of schizophrenia in both humans and rodents. In mice, subchronic ketamine...